Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Means and methods for treating DLBCL

Means and methods for treating DLBCL

US Patent 9192665 · Granted Nov 24, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prevention of adverse effects caused by CD3 specific binding domains2023
Prevention of adverse effects caused by CD3 specific binding domains2023
Prevention of adverse effects caused by CD3 specific binding domains2023
Treatment of acute lymphoblastic leukemia2023
Dosage regimen for administering a CD19xCD3 bispecific antibody to patients at r2023
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by2021
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by2021
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by2021
Risk-stratification of B-precursor acute lymphoblastic leukemia patients2021
Administration of a bispecific construct binding to CD33 and CD3 for use in a me2021
Means and methods for treating DLBCL2020
Means and methods for treating DLBCL2020